Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic retinal angiogenesis into the vitreous, termed intravitreal neovascularization (IVNV). Although agents that interfere with the bioactivity of vascu...
Uloženo v:
| Vydáno v: | Frontiers in pediatrics Ročník 9; s. 796143 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
Frontiers Media S.A
09.12.2021
|
| Témata: | |
| ISSN: | 2296-2360, 2296-2360 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic retinal angiogenesis into the vitreous, termed intravitreal neovascularization (IVNV). Although agents that interfere with the bioactivity of vascular endothelial growth factor (VEGF) are now used to treat IVNV, concerns exist regarding the identification of optimal doses of anti-VEGF for individual infants and the effect of broad VEGF inhibition on physiologic angiogenesis in external organs or in the retina of a preterm infant. Therefore, it is important to understand VEGF signaling in both physiologic and pathologic angiogenesis in the retina. In this manuscript, we review the role of receptors that interact with VEGF in oxygen-induced retinopathy (OIR) models that represent features of ROP pathology. Specifically, we discuss our work regarding the regulation of VEGFR2 signaling in retinal endothelial cells to not only reduce severe ROP but also facilitate physiologic retinal vascular and neuronal development. |
|---|---|
| AbstractList | Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic retinal angiogenesis into the vitreous, termed intravitreal neovascularization (IVNV). Although agents that interfere with the bioactivity of vascular endothelial growth factor (VEGF) are now used to treat IVNV, concerns exist regarding the identification of optimal doses of anti-VEGF for individual infants and the effect of broad VEGF inhibition on physiologic angiogenesis in external organs or in the retina of a preterm infant. Therefore, it is important to understand VEGF signaling in both physiologic and pathologic angiogenesis in the retina. In this manuscript, we review the role of receptors that interact with VEGF in oxygen-induced retinopathy (OIR) models that represent features of ROP pathology. Specifically, we discuss our work regarding the regulation of VEGFR2 signaling in retinal endothelial cells to not only reduce severe ROP but also facilitate physiologic retinal vascular and neuronal development. Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic retinal angiogenesis into the vitreous, termed intravitreal neovascularization (IVNV). Although agents that interfere with the bioactivity of vascular endothelial growth factor (VEGF) are now used to treat IVNV, concerns exist regarding the identification of optimal doses of anti-VEGF for individual infants and the effect of broad VEGF inhibition on physiologic angiogenesis in external organs or in the retina of a preterm infant. Therefore, it is important to understand VEGF signaling in both physiologic and pathologic angiogenesis in the retina. In this manuscript, we review the role of receptors that interact with VEGF in oxygen-induced retinopathy (OIR) models that represent features of ROP pathology. Specifically, we discuss our work regarding the regulation of VEGFR2 signaling in retinal endothelial cells to not only reduce severe ROP but also facilitate physiologic retinal vascular and neuronal development.Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic retinal angiogenesis into the vitreous, termed intravitreal neovascularization (IVNV). Although agents that interfere with the bioactivity of vascular endothelial growth factor (VEGF) are now used to treat IVNV, concerns exist regarding the identification of optimal doses of anti-VEGF for individual infants and the effect of broad VEGF inhibition on physiologic angiogenesis in external organs or in the retina of a preterm infant. Therefore, it is important to understand VEGF signaling in both physiologic and pathologic angiogenesis in the retina. In this manuscript, we review the role of receptors that interact with VEGF in oxygen-induced retinopathy (OIR) models that represent features of ROP pathology. Specifically, we discuss our work regarding the regulation of VEGFR2 signaling in retinal endothelial cells to not only reduce severe ROP but also facilitate physiologic retinal vascular and neuronal development. |
| Author | Hartnett, M. Elizabeth Ramshekar, Aniket |
| AuthorAffiliation | Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah , Salt Lake City, UT , United States |
| AuthorAffiliation_xml | – name: Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah , Salt Lake City, UT , United States |
| Author_xml | – sequence: 1 givenname: Aniket surname: Ramshekar fullname: Ramshekar, Aniket – sequence: 2 givenname: M. Elizabeth surname: Hartnett fullname: Hartnett, M. Elizabeth |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34956992$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kl9vFCEUxSemxtbad58Mj77MOsMwMPhgYpq2btKmxn-v5A4wMzQsrMCo-1H8trK7tdmayAuEe87vEu55Xhw573RRvKyrRdN0_M2w1mqBK1wvGKc1aZ4UJxhzWuKGVkcH5-PiLMa7Ki_OqrZunxXHDeEt5RyfFL-_QZSzhYAunPJp0taARVfB_0wTugSZfECfzejAGjci49CNV9pG5Ad0-2szalcunZqlVuiTTsb5NaRp8xYtXTTjlGI-JI9utJzAmbja-T5mibd-3GxxB65dLegVpDmYtHlRPB3ARn12v58WXy8vvpx_KK9vr5bn769LSShOJaEdHholO80raNlAGZNNqxipqOK1ajBQSQbQVZY0A9G06_paEjwAk7zP33ZaLPdc5eFOrINZQdgID0bsLnwYBYRkpNWCQU8HCS3UkhPNcU8klrJXoNkgKeky692etZ77lVZSuxTAPoI-rjgzidH_EB3NI2x5Bry-BwT_fdYxiZWJUlsLTvs5CpwHzdqWsjpLXx32emjyd7ZZUO0FMvgYgx4eJHUltgkS2wSJbYLEPkHZQv-xSJMgGb99rbH_N_4BnhnQJw |
| CitedBy_id | crossref_primary_10_1111_dmcn_15468 crossref_primary_10_1038_s41598_022_27201_y crossref_primary_10_3389_fphar_2022_1033341 crossref_primary_10_3390_antiox13020148 crossref_primary_10_3390_children10030567 crossref_primary_10_3390_ijms23137354 crossref_primary_10_1038_s41580_023_00631_w crossref_primary_10_1146_annurev_vision_093022_021420 crossref_primary_10_1016_j_preteyeres_2023_101230 crossref_primary_10_1186_s12993_023_00216_9 crossref_primary_10_3390_cells11142185 crossref_primary_10_3390_ijms25158461 crossref_primary_10_1016_j_exer_2025_110422 crossref_primary_10_1161_CIRCRESAHA_123_323398 crossref_primary_10_2147_IJGM_S401122 crossref_primary_10_1167_iovs_63_8_25 |
| Cites_doi | 10.1016/S0002-9440(10)64773-6 10.1001/jamaophthalmol.2017.1055 10.1167/iovs.08-1780 10.2147/EB.S94443 10.1016/j.preteyeres.2016.02.003 10.1016/j.ajpath.2013.05.011 10.1016/j.jaapos.2012.12.155 10.1001/archophthalmol.2010.158 10.1159/000336639 10.1167/iovs.13-11625 10.1002/path.2611 10.1038/380435a0 10.1182/blood.V99.7.2397 10.1074/jbc.C800137200 10.1016/j.cell.2019.01.021 10.1038/376062a0 10.1001/archopht.121.12.1684 10.1167/iovs.13-13755 10.1016/j.ophtha.2014.07.050 10.1096/fj.00-0598fje 10.1016/j.ophtha.2021.05.031 10.1167/iovs.10-6798 10.1159/000330174 10.1074/jbc.M102315200 10.1203/00006450-199412000-00007 10.1001/archophthalmol.2010.65 10.1172/JCI17808 10.1002/jcb.10140 10.1046/j.1442-9071.2003.00602.x 10.1016/S0022-3476(97)70031-3 10.1038/nrm.2016.87 10.1056/NEJMra1208129 10.1167/iovs.13-12171 10.1016/j.clp.2014.08.011 10.1016/s0896-6273(00)80371-2 10.1016/s1050-1738(01)00140-2 10.1167/iovs.15-18598 10.1038/380439a0 10.1001/jamaophthalmol.2020.0334 10.1006/mvre.1998.2111 10.1016/j.ophtha.2018.05.001 10.1096/fasebj.13.1.9 10.1182/blood-2006-07-037952 10.1016/s0896-6273(00)80392-x 10.2119/2004-00017.Campochiaro 10.15252/emmm.201404922 10.1242/dev.103028 10.1038/nm731 10.1007/s10456-018-9618-5 10.1371/journal.pone.0021411 10.1136/bjo.38.7.397 10.1242/dev.070037 10.1016/S0140-6736(19)31344-3 10.1016/S0002-9440(10)63001-5 10.1042/BST20140244 10.1002/14651858.CD009734.pub3 10.1073/pnas.0805817105 10.1242/dev.126.21.4895 10.1038/nrm1911 10.1016/S0021-9258(18)47298-5 10.1056/NEJMoa1007374 10.1016/0012-1606(87)90335-6 10.1542/peds.75.4.619 10.1053/j.semperi.2019.05.001 10.1002/glia.20997 10.1073/pnas.92.3.905 10.1038/nrc2404 10.1038/s41598-018-20278-4 10.1073/pnas.012074399 10.3109/08977199809017487 10.1016/s0092-8674(00)80534-6 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021 Ramshekar and Hartnett. Copyright © 2021 Ramshekar and Hartnett. 2021 Ramshekar and Hartnett |
| Copyright_xml | – notice: Copyright © 2021 Ramshekar and Hartnett. – notice: Copyright © 2021 Ramshekar and Hartnett. 2021 Ramshekar and Hartnett |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fped.2021.796143 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2296-2360 |
| ExternalDocumentID | oai_doaj_org_article_7ab6fca5a1c94e92b4c2ccbdae7fc648 PMC8696159 34956992 10_3389_fped_2021_796143 |
| Genre | Journal Article Review |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM ACXDI EMOBN IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c462t-4682f3dc8e90a57f677c35d7406d91d32a6c4fae0dc83f4e688b1c42fa7c9b143 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 20 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000738738100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2296-2360 |
| IngestDate | Fri Oct 03 12:53:26 EDT 2025 Thu Aug 21 14:02:06 EDT 2025 Fri Sep 05 13:29:30 EDT 2025 Thu Jan 02 22:55:20 EST 2025 Sat Nov 29 02:51:50 EST 2025 Tue Nov 18 22:02:43 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | VEGFRs neuropilins OIR ROP VEGF receptors VEGF |
| Language | English |
| License | Copyright © 2021 Ramshekar and Hartnett. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-4682f3dc8e90a57f677c35d7406d91d32a6c4fae0dc83f4e688b1c42fa7c9b143 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Alison Chu, University of California, Los Angeles, United States This article was submitted to Neonatology, a section of the journal Frontiers in Pediatrics Reviewed by: Paola Bagnoli, University of Pisa, Italy |
| OpenAccessLink | https://doaj.org/article/7ab6fca5a1c94e92b4c2ccbdae7fc648 |
| PMID | 34956992 |
| PQID | 2614755671 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7ab6fca5a1c94e92b4c2ccbdae7fc648 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8696159 proquest_miscellaneous_2614755671 pubmed_primary_34956992 crossref_primary_10_3389_fped_2021_796143 crossref_citationtrail_10_3389_fped_2021_796143 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-09 |
| PublicationDateYYYYMMDD | 2021-12-09 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-09 day: 09 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pediatrics |
| PublicationTitleAlternate | Front Pediatr |
| PublicationYear | 2021 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Hartnett (B76) 2013; 17 Hartnett (B33) 2014; 41 B22 Hartnett (B2) 2012; 367 McLeod (B15) 2016; 8 McCloskey (B25) 2013; 54 Weidemann (B27) 2010; 58 Johnson (B73) 1985 Wallace (B10) 2018; 125 Fantin (B64) 2011; 138 Ashton (B4) 1954; 38 Fantin (B68) 2014; 141 Hartnett (B44) 2008; 49 Trichonas (B74) 2013; 54 Apte (B17) 2019; 176 Suzuma (B36) 1998; 56 Ozaki (B45) 2000; 156 Kawasaki (B59) 1999; 126 Whitaker (B65) 2001; 276 Raju (B72) 1997; 131 Robbins (B37) 1998; 16 Chen (B49) 1997; 19 Simons (B34) 2016; 17 Zeng (B42) 2007; 109 Penn (B13) 1994; 36 Park (B41) 1994; 269 Takagi (B48) 1987; 122 Jiang (B30) 2014; 55 Wallace (B8) 2017; 135 Wallace (B9) 2020; 138 Al-Shabrawey (B70) 2005; 167 Dejda (B63) 2016; 57 Parad (B71) 2012; 102 Yang (B56) 2015; 7 Mintz-Hittner (B7) 2011; 364 He (B50) 1997; 90 Shih (B40) 2003; 112 Sears (B75) 2008; 105 Neufeld (B53) 1999; 13 Raimondi (B62) 2016; 52 Huang (B38) 2011; 6 Hartnett (B5) 2015; 122 Robinson (B46) 2001; 15 Carmeliet (B18) 1996; 380 Rivera (B77) 2011; 100 Kitsukawa (B60) 1997; 19 Wang (B31) 2013; 183 Oh (B55) 2002; 99 (B6) 2003; 121 Becker (B32) 2018; 8 Olsson (B35) 2006; 7 Reichelt (B21) 2003; 31 Sankar (B11) 2018; 1 Geisen (B23) 2008; 14 Pierce (B29) 1995; 92 Budd (B58) 2010; 128 B54 Ferrara (B19) 1996; 380 B12 Kearney (B43) 2002; 99 B14 Stahl (B69) 2019; 394 B16 Chiang (B3) 2021; 128 Shalaby (B20) 1995; 376 Bai (B28) 2009; 219 Shen (B57) 2004; 10 Lampropoulou (B61) 2014; 42 Soker (B66) 2002; 85 Budd (B24) 2010; 128 Luttun (B39) 2002; 8 Simmons (B47) 2018; 21 Neufeld (B52) 2008; 8 Darlow (B1) 2019; 43 Neufeld (B51) 2002; 12 Lutty (B26) 2011; 52 Prahst (B67) 2008; 283 |
| References_xml | – ident: B12 – volume: 156 start-page: 697 year: 2000 ident: B45 article-title: Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization publication-title: Am J Pathol. doi: 10.1016/S0002-9440(10)64773-6 – volume: 135 start-page: 654 year: 2017 ident: B8 article-title: Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study publication-title: JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2017.1055 – volume: 49 start-page: 3107 year: 2008 ident: B44 article-title: Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.08-1780 – volume: 8 start-page: 55 year: 2016 ident: B15 article-title: Targeting VEGF in canine oxygen-induced retinopathy - a model for human retinopathy of prematurity publication-title: Eye Brain. doi: 10.2147/EB.S94443 – volume: 52 start-page: 64 year: 2016 ident: B62 article-title: NRP1 function and targeting in neurovascular development and eye disease publication-title: Prog Retin Eye Res. doi: 10.1016/j.preteyeres.2016.02.003 – volume: 183 start-page: 964 year: 2013 ident: B31 article-title: Short hairpin RNA-mediated knockdown of VEGFA in Muller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity publication-title: Am J Pathol. doi: 10.1016/j.ajpath.2013.05.011 – volume: 17 start-page: 229 year: 2013 ident: B76 article-title: Effects of oxygen on the development and severity of retinopathy of prematurity publication-title: J AAPOS. doi: 10.1016/j.jaapos.2012.12.155 – volume: 128 start-page: 1014 year: 2010 ident: B24 article-title: Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity publication-title: Arch Ophthalmol. doi: 10.1001/archophthalmol.2010.158 – volume: 102 start-page: 139 year: 2012 ident: B71 article-title: Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase publication-title: Neonatology. doi: 10.1159/000336639 – volume: 54 start-page: 2020 year: 2013 ident: B25 article-title: Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.13-11625 – volume: 219 start-page: 446 year: 2009 ident: B28 article-title: Muller cell-derived VEGF is a significant contributor to retinal neovascularization publication-title: J Pathol. doi: 10.1002/path.2611 – ident: B16 – volume: 380 start-page: 435 year: 1996 ident: B18 article-title: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele publication-title: Nature. doi: 10.1038/380435a0 – volume: 99 start-page: 2397 year: 2002 ident: B43 article-title: Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division publication-title: Blood. doi: 10.1182/blood.V99.7.2397 – volume: 283 start-page: 25110 year: 2008 ident: B67 article-title: Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1 publication-title: J Biol Chem. doi: 10.1074/jbc.C800137200 – volume: 176 start-page: 1248 year: 2019 ident: B17 article-title: VEGF in signaling and disease: beyond discovery and development publication-title: Cell. doi: 10.1016/j.cell.2019.01.021 – ident: B54 – volume: 376 start-page: 62 year: 1995 ident: B20 article-title: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice publication-title: Nature. doi: 10.1038/376062a0 – volume: 121 start-page: 1684 year: 2003 ident: B6 article-title: Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.12.1684 – volume: 55 start-page: 824 year: 2014 ident: B30 article-title: Targeting muller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.13-13755 – volume: 122 start-page: 200 year: 2015 ident: B5 article-title: Pathophysiology and mechanisms of severe retinopathy of prematurity publication-title: Ophthalmology. doi: 10.1016/j.ophtha.2014.07.050 – volume: 15 start-page: 1215 year: 2001 ident: B46 article-title: Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development publication-title: FASEB J. doi: 10.1096/fj.00-0598fje – volume: 128 start-page: e51 year: 2021 ident: B3 article-title: International classification of retinopathy of prematurity, third edition publication-title: Ophthalmology. doi: 10.1016/j.ophtha.2021.05.031 – volume: 52 start-page: 4039 year: 2011 ident: B26 article-title: Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.10-6798 – volume: 100 start-page: 343 year: 2011 ident: B77 article-title: Understanding retinopathy of prematurity: update on pathogenesis publication-title: Neonatology. doi: 10.1159/000330174 – volume: 276 start-page: 25520 year: 2001 ident: B65 article-title: Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121 publication-title: J Biol Chem. doi: 10.1074/jbc.M102315200 – volume: 36 start-page: 724 year: 1994 ident: B13 article-title: Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat publication-title: Pediatr Res. doi: 10.1203/00006450-199412000-00007 – volume: 128 start-page: 589 year: 2010 ident: B58 article-title: Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity publication-title: ArchOphthalmol. doi: 10.1001/archophthalmol.2010.65 – volume: 112 start-page: 50 year: 2003 ident: B40 article-title: Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity publication-title: J Clin Invest. doi: 10.1172/JCI17808 – volume: 85 start-page: 357 year: 2002 ident: B66 article-title: VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding publication-title: J Cell Biochem. doi: 10.1002/jcb.10140 – volume: 31 start-page: 61 year: 2003 ident: B21 article-title: Vascular endothelial growth factor-B and retinal vascular development in the mouse publication-title: Clin Exp Ophthalmol. doi: 10.1046/j.1442-9071.2003.00602.x – volume: 131 start-page: 844 year: 1997 ident: B72 article-title: Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials publication-title: J Pediatrics. doi: 10.1016/S0022-3476(97)70031-3 – volume: 17 start-page: 611 year: 2016 ident: B34 article-title: Mechanisms and regulation of endothelial VEGF receptor signalling publication-title: Nat Rev Mol Cell Biol. doi: 10.1038/nrm.2016.87 – volume: 367 start-page: 2515 year: 2012 ident: B2 article-title: Mechanisms and management of retinopathy of prematurity publication-title: N Engl J Med. doi: 10.1056/NEJMra1208129 – volume: 54 start-page: 4919 year: 2013 ident: B74 article-title: Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.13-12171 – volume: 41 start-page: 925 year: 2014 ident: B33 article-title: Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity publication-title: Clin Perinatol. doi: 10.1016/j.clp.2014.08.011 – volume: 19 start-page: 547 year: 1997 ident: B49 article-title: Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III publication-title: Neuron. doi: 10.1016/s0896-6273(00)80371-2 – volume: 12 start-page: 13 year: 2002 ident: B51 article-title: The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis publication-title: Trends Cardiovasc Med. doi: 10.1016/s1050-1738(01)00140-2 – volume: 57 start-page: 1530 year: 2016 ident: B63 article-title: Neuropilin-1-expressing microglia are associated with nascent retinal vasculature yet dispensable for developmental angiogenesis publication-title: Invest Ophthalmol Vis Sci. doi: 10.1167/iovs.15-18598 – volume: 380 start-page: 439 year: 1996 ident: B19 article-title: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene publication-title: Nature. doi: 10.1038/380439a0 – volume: 138 start-page: 698 year: 2020 ident: B9 article-title: Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity publication-title: JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2020.0334 – ident: B14 – volume: 56 start-page: 183 year: 1998 ident: B36 article-title: Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization publication-title: Microvasc Res. doi: 10.1006/mvre.1998.2111 – volume: 125 start-page: 1961 year: 2018 ident: B10 article-title: A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments publication-title: Ophthalmology. doi: 10.1016/j.ophtha.2018.05.001 – volume: 13 start-page: 9 year: 1999 ident: B53 article-title: Vascular endothelial growth factor (VEGF) and its receptors publication-title: FASEB J. doi: 10.1096/fasebj.13.1.9 – volume: 109 start-page: 1345 year: 2007 ident: B42 article-title: Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation publication-title: Blood. doi: 10.1182/blood-2006-07-037952 – volume: 19 start-page: 995 year: 1997 ident: B60 article-title: Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice publication-title: Neuron. doi: 10.1016/s0896-6273(00)80392-x – volume: 10 start-page: 12 year: 2004 ident: B57 article-title: Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization publication-title: Mol Med. doi: 10.2119/2004-00017.Campochiaro – volume: 7 start-page: 1267 year: 2015 ident: B56 article-title: Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis publication-title: EMBO Mol Med. doi: 10.15252/emmm.201404922 – volume: 141 start-page: 556 year: 2014 ident: B68 article-title: Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis publication-title: Development. doi: 10.1242/dev.103028 – volume: 8 start-page: 831 year: 2002 ident: B39 article-title: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 publication-title: Nat Med. doi: 10.1038/nm731 – volume: 21 start-page: 751 year: 2018 ident: B47 article-title: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy publication-title: Angiogenesis. doi: 10.1007/s10456-018-9618-5 – volume: 6 start-page: e21411 year: 2011 ident: B38 article-title: Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye publication-title: PLoS ONE. doi: 10.1371/journal.pone.0021411 – volume: 38 start-page: 397 year: 1954 ident: B4 article-title: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia publication-title: Br J Ophthalmol. doi: 10.1136/bjo.38.7.397 – volume: 138 start-page: 4185 year: 2011 ident: B64 article-title: The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins publication-title: Development. doi: 10.1242/dev.070037 – volume: 14 start-page: 345 year: 2008 ident: B23 article-title: Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity publication-title: Mol Vis. – volume: 394 start-page: 1551 year: 2019 ident: B69 article-title: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial publication-title: Lancet. doi: 10.1016/S0140-6736(19)31344-3 – volume: 167 start-page: 599 year: 2005 ident: B70 article-title: Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy publication-title: Am J Pathol. doi: 10.1016/S0002-9440(10)63001-5 – volume: 42 start-page: 1623 year: 2014 ident: B61 article-title: Neuropilin regulation of angiogenesis publication-title: Biochem Soc Trans. doi: 10.1042/BST20140244 – volume: 1 start-page: Cd009734 year: 2018 ident: B11 article-title: Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD009734.pub3 – volume: 105 start-page: 19898 year: 2008 ident: B75 article-title: Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy publication-title: Proc Nat Acad Sci. doi: 10.1073/pnas.0805817105 – volume: 126 start-page: 4895 year: 1999 ident: B59 article-title: A requirement for neuropilin-1 in embryonic vessel formation publication-title: Development. doi: 10.1242/dev.126.21.4895 – volume: 7 start-page: 359 year: 2006 ident: B35 article-title: VEGF receptor signalling - in control of vascular function publication-title: Nat Rev Mol Cell Biol. doi: 10.1038/nrm1911 – volume: 269 start-page: 25646 year: 1994 ident: B41 article-title: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR publication-title: J Biol Chemistry doi: 10.1016/S0021-9258(18)47298-5 – ident: B22 – volume: 364 start-page: 603 year: 2011 ident: B7 article-title: Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity publication-title: N Engl J Med. doi: 10.1056/NEJMoa1007374 – volume: 122 start-page: 90 year: 1987 ident: B48 article-title: Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies publication-title: Dev Biol. doi: 10.1016/0012-1606(87)90335-6 – start-page: 619 year: 1985 ident: B73 article-title: Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less publication-title: Pediatrics doi: 10.1542/peds.75.4.619 – volume: 43 start-page: 315 year: 2019 ident: B1 article-title: Retinopathy of prematurity - a world update publication-title: Semin Perinatol. doi: 10.1053/j.semperi.2019.05.001 – volume: 58 start-page: 1177 year: 2010 ident: B27 article-title: Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina publication-title: Glia. doi: 10.1002/glia.20997 – volume: 92 start-page: 905 year: 1995 ident: B29 article-title: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.92.3.905 – volume: 8 start-page: 632 year: 2008 ident: B52 article-title: The semaphorins: versatile regulators of tumour progression and tumour angiogenesis publication-title: Nat Rev Cancer. doi: 10.1038/nrc2404 – volume: 8 start-page: 2003 year: 2018 ident: B32 article-title: Targeted knockdown of overexpressed VEGFA or VEGF164 in muller cells maintains retinal function by triggering different signaling mechanisms publication-title: Sci Rep. doi: 10.1038/s41598-018-20278-4 – volume: 99 start-page: 383 year: 2002 ident: B55 article-title: Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis publication-title: Proc Nat Acad Sci U S A. doi: 10.1073/pnas.012074399 – volume: 16 start-page: 1 year: 1998 ident: B37 article-title: Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina publication-title: Growth Factors. doi: 10.3109/08977199809017487 – volume: 90 start-page: 739 year: 1997 ident: B50 article-title: Neuropilin is a receptor for the axonal chemorepellent Semaphorin III publication-title: Cell. doi: 10.1016/s0092-8674(00)80534-6 |
| SSID | ssj0000970515 |
| Score | 2.3027353 |
| SecondaryResourceType | review_article |
| Snippet | Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 796143 |
| SubjectTerms | neuropilins OIR Pediatrics ROP VEGF VEGF receptors VEGFRs |
| Title | Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34956992 https://www.proquest.com/docview/2614755671 https://pubmed.ncbi.nlm.nih.gov/PMC8696159 https://doaj.org/article/7ab6fca5a1c94e92b4c2ccbdae7fc648 |
| Volume | 9 |
| WOSCitedRecordID | wos000738738100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2296-2360 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000970515 issn: 2296-2360 databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2296-2360 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000970515 issn: 2296-2360 databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZghRAXxHvLY2UkLhxCN47jBzdALSDRZcVLvUXO2N6NVJJVk0X0wv_g3-JxslWKEFy4RFH8yMgzfozG832EPIHSCJ1al0DubcINhHXQWZWUpTY-9cyBjTiz7-TRkVou9fGI6gvvhPXwwP3ATaXBdBSTmxQ0d5qVHBhAaY2THgSPab7h1DNypuIarCWSl_RxyeCF6ak_cwgMytJnUouYpDPahyJc_5_OmL9flRztPfMb5PpwaKQvemFvkkuuvkWuLoaw-G3y88twn5TOaospVatgVfR18LC7UzqPjDr0Y3WCZ-76hFY1RQa0VUsbT99_3wQTSpDBA5ylHzADukGa4s1z-rZu0XVvw0vX0IXDJOGq_RrbHZsurpsb7G7UKpatEQg20uLdIZ_ns0-v3iQD50ICXLAu4UIxn1lQTh-aXHohJWS5lWHft0GnGTMCuDfuMFTJPHdCqTIFzryRoMswrnfJXt3Ubp9QjAFLZaW3ZcZBZtq40LNl0mojlM0nZHqhgQIGQHLkxVgVwTFBnRWoswJ1VvQ6m5Cn2xZnPRjHX-q-RKVu6yGMdvwQjKsYjKv4l3FNyOMLkyjCtMNYiqldc94WwfHkMs-FTCfkXm8i219l6HRqzSZE7hjPjiy7JXV1GqG9lQjC5_r-_xD-AbmG4xHv3uiHZK9bn7tH5Ap866p2fUAuy6U6iLMmPBc_Zr8A-Jkl0Q |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vascular+Endothelial+Growth+Factor+Signaling+in+Models+of+Oxygen-Induced+Retinopathy%3A+Insights+Into+Mechanisms+of+Pathology+in+Retinopathy+of+Prematurity&rft.jtitle=Frontiers+in+pediatrics&rft.au=Ramshekar%2C+Aniket&rft.au=Hartnett%2C+M+Elizabeth&rft.date=2021-12-09&rft.issn=2296-2360&rft.eissn=2296-2360&rft.volume=9&rft.spage=796143&rft_id=info:doi/10.3389%2Ffped.2021.796143&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-2360&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-2360&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-2360&client=summon |